FDA Approved: AJOVY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AJOVY (fremanezumab) submitted by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Ajovy (fremanezumab)

Snippet

SUPPL AP for AJOVY (FREMANEZUMAB-VFRM)